Liquidia settles patent lawsuit with United Therapeutics

Liquidia Technologies has entered into a settlement agreement with United Therapeutics Corporation to resolve their Contested Proceedings without admitting any infringement or wrongdoing. The settlement likely resolves a patent dispute. The legal proceedings were redacted in the filing. This settlement removes a significant uncertainty regarding potential future litigation costs and liability.